Eli Lilly and Co
1LLY
Company Profile
Business description
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Contact
Lilly Corporate Center
IndianapolisIN46285
USAT: +1 317 276-2000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
47,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,660.30 | 22.50 | 0.26% |
CAC 40 | 7,751.89 | 27.83 | -0.36% |
DAX 40 | 23,997.48 | 64.25 | 0.27% |
Dow JONES (US) | 42,270.07 | 54.34 | 0.13% |
FTSE 100 | 8,772.38 | 55.93 | 0.64% |
HKSE | 23,289.77 | 283.61 | -1.20% |
NASDAQ | 19,113.77 | 62.10 | -0.32% |
Nikkei 225 | 37,965.10 | 467.88 | -1.22% |
NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
S&P 500 | 5,911.69 | 0.48 | -0.01% |
S&P/ASX 200 | 8,434.70 | 24.90 | 0.30% |
SSE Composite Index | 3,347.49 | 15.96 | -0.47% |